TY  - CHAP
M1  - Book, Section
TI  - Circulatory Shock Syndromes
A1  - Boucher, Bradley A.
A1  - Wood, G. Christopher
A2  - Chisholm-Burns, Marie A.
A2  - Schwinghammer, Terry L.
A2  - Malone, Patrick M.
A2  - Kolesar, Jill M.
A2  - Bookstaver, P. Brandon
A2  - Lee, Kelly C.
PY  - 2022
T2  - Pharmacotherapy Principles & Practice, 6e
AB  - LEARNING  OBJECTIVESUpon  completion  of  the  chapter,  the  reader  will  be  able  to:List  the  most  common  conditions  resulting  in  the  following  circulatory  shock  syndromes:  hypovolemic,  cardiogenic,  and  obstructive.Describe  the  major  hemodynamic  and  metabolic  abnormalities  that  occur  in  patients  with  circulatory  shock.Describe  the  clinical  presentation  including  signs,  symptoms,  and  laboratory  test  measurements  for  the  typical  circulatory  shock  patient.Prepare  a  treatment  plan  with  clearly  defined  outcome  criteria  for  hypovolemic,  cardiogenic,  and  obstructive  shock  patients,  including  fluid  management,  pharmacologic  therapy,  and/or  surgical/mechanical  interventions.Compare  and  contrast  relative  advantages  and  disadvantages  of  crystalloids,  colloids,  and  blood  products  in  treating  hypovolemic  shock.Formulate  a  stepwise  monitoring  strategy  for  patients  with  hypovolemic,  cardiogenic,  and  obstructive  shock.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/20
UR  - ppp.mhmedical.com/content.aspx?aid=1187008113
ER  -